Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixprim vs Dafalgan-Codeine for Moderate Pain in Emergency Unit
NCT01782846Phase 4Completed
- Sponsor
- Hôpital Foch
- Start
- Mar 2011
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Ixprim, Dafalgan + codeine in pain, sponsored by Hôpital Foch. Started Mar 2011; status: completed.
02
Drugs
IxprimDafalgan + codeine
03
Conditions
pain
Beyond the preview
Go deeper on NCT01782846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01782846.